Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa

Health
By BY KATIE THOMAS, CARL ZIMMER AND SHARON LAFRANIERE from NYT Health https://ift.tt/3t04Lwl
via IFTTT Vaccination and Immunization, Clinical Trials, Coronavirus (2019-nCoV), your-feed-science An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda